Technology AstraZeneca signs a deal worth up to $247M with US-based Absci Corp. to harness Absci's AI tech for large-scale protein analysis to find a viable cancer therapy (Michael Peel/Financial Times)
Mobile Leaked Internal memo from T-Mobile COO Freier reveals official date when T-Mobile goes 100% digital
Mobile We asked, you answered: Android users pick between gestures and 3-button navigation, and the top choice might surprise you
